Comparing two ways to lower cholesterol after heart artery treatment
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study compares two ways of measuring fats in your blood to decide how to lower cholesterol after a heart artery procedure. It aims to find which approach works better to reduce the risk of future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had a heart artery procedure (percutaneous coronary intervention) with a drug-eluting stent.
- You are willing to give your permission to join the study.
- You do not have a serious illness that limits your life to less than 12 months.
- You do not have significant liver disease or a condition that prevents you from taking cholesterol-lowering medicines.
- You do not have any other condition that would make it hard to follow the study's schedule or instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether reaching a very low LDL cholesterol level (below 1.0 mmol/L) is better than a slightly higher target (1.0-1.8 mmol/L) for people at very high risk after receiving a heart stent. It aims to reduce future heart problems.
This trial studies how to lower “bad” cholesterol (LDL) in people age 75 and older who have already had heart, brain, or leg/blood-vessel problems from blocked arteries. The goal is to see if the approach helps prevent further cardiovascular events (like heart attack or stroke).
This study tests a team-based approach to help people with artery disease (like heart attacks or leg blockages) get their cholesterol to a healthier level. If your LDL is above 70, you may benefit from extra support to manage your medications.
This study compares two ways to lower cholesterol and stabilize artery plaque in people with coronary artery disease who are having a stent procedure. It tests whether a moderate statin plus ezetimibe works as well as a high-intensity statin alone for stabilizing plaque.
This trial tests whether a single injection of a PCSK9 inhibitor (a cholesterol-lowering medicine) can improve heart health after a stent procedure. It is for people who have a certain amount of fat buildup in their treated artery.
This study tests whether a clinical pharmacist-led team can help manage LDL cholesterol levels in patients with heart or blood vessel disease. It aims to improve care for people with conditions like coronary artery disease, stroke, or peripheral artery disease.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.